NCT00109252View on ClinicalTrials.gov

A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g

PHASE3CompletedINTERVENTIONAL
0
Timeline

Start Date

January 31, 2002

Study Completion Date

April 30, 2003

Conditions
Psoriasis
Interventions
DRUG

Raptiva (efalizumab)

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY